Comparison of the Safety and Effectiveness of Lower Extremity Artery Bypass Grafting and Endovascular Angioplasty in the Treatment of Lower Extremity Arteriosclerosis Obliterans in the Elderly

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (5847 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To compare the safety and effectiveness of lower extremity artery bypass grafting and endovascular angioplasty in the treatment of lower extremity arteriosclerosis obliterans in the elderly. Methods: The data of 87 elderly patients with lower extremity arteriosclerosis obliterans treated in our hospital from August 2015 to August 2017 were analyzed retrospectively. According to the different treatment methods, they were divided into angioplasty group (n=45, intravascular angioplasty) and bypass grafting group (n=42, lower extremity artery bypass grafting). The success rate, hemodynamics of dorsalis pedis artery and nerve conduction of lower extremity were compared between the two groups Velocity, VAS score, late target vessel lumen loss (LLL), patency rate, restenosis rate, ankle brachial index (ABI) and clinical adverse events. Results: There was no significant difference between angioplasty group and bypass group (P>0.05). One month after operation, the hemodynamics of dorsalis pedis artery and nerve conduction velocity of lower limbs in the two groups were better than those before operation, the difference was statistically significant (P<0.05), but there was no significant difference between the two groups (P>0.05). The VAS score of the two groups was significantly lower than that of the preoperative group (P<0.05), but there was no significant difference between the two groups (P>0.05). The ABI of the two groups was significantly improved after operation, the difference was statistically significant (P<0.05), but there was no significant difference between the groups at each time point (P>0.05). There was no significant difference in LLL, patency rate and restenosis rate between the two groups (P>0.05). There was statistical difference in the incidence of complications between the two groups (P<0.05). During the follow-up period, no serious adverse events such as death or amputation occurred in both groups. Conclusion: Endovascular angioplasty and lower extremity artery bypass grafting have the same clinical effect in the treatment of elderly patients with lower extremity arteriosclerosis obliterans, which are safe and feasible.

Key words： lower extremity artery bypass grafting endovascular angioplasty arteriosclerosis obliterans of lower extremity

Received: 15 December 2018

Corresponding Authors: ZHAO Jing-hao. E-mail: jhzhao@sina.com

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Gang-zhi
	ZHAO Jin-jie
	MA Ronga
	LI Lan-lan
	ZHAO Jing-hao

Cite this article:

LI Gang-zhi,ZHAO Jin-jie,MA Ronga, et al. Comparison of the Safety and Effectiveness of Lower Extremity Artery Bypass Grafting and Endovascular Angioplasty in the Treatment of Lower Extremity Arteriosclerosis Obliterans in the Elderly[J]. Chinese Journal of Biomedical Engineering, 2019, 28(1): 13-21.

URL:

http://manu32.magtech.com.cn/Jwk_zgswyx_en/EN/ OR http://manu32.magtech.com.cn/Jwk_zgswyx_en/EN/Y2019/V28/I1/13

[1] Akagi D, Hoshina K, Akai A, et al.Outcomes in patients with critical limb ischemia due to arteriosclerosis obliterans who did not undergo arterial reconstruction[J]. Int Heart J, 2018,59(5): 1041-1046.
[2] European Stroke Organisation, Tendera M, Aboyans V, et al.ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2011, 32(22): 2851-906.
[3] Halliday A, Bax JJ.The 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)[J]. Eur J Vasc Endovasc Surg, 2018,55(3): 301-302.
[4] SEC Working Group for the 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, Pérez de Isla L, Moux G, et al. Comments on the 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases[J]. Rev Esp Cardiol (Engl Ed), 2018,71(2): 74-78.
[5] Zhou YB, Wu DM.Endovascular surgery for lower extremity atherosclerotic lesions[J]. Chinese Journal of General Surgery, 2014,23(6): 727-731.
[6] Zhang YJ, Huo X, Liu B.Treatment of lower extremity arterial occlusion[J]. Chinese Journal of General Surgery, 2010,19(12): 1274-1275.
[7] Shen SK, Wu DM, Wang CG, et al.A meta-analysis of bypass grafting and endovascular therapy for severe lower extremity arterial occlusive diseases[J]. Chinese Medical Journal, 2017,97(30): 2372-2378.
[8] Wu YF, Gu YQ, Li XF, et al.Preliminary evaluation of clinical effect of inferior genicular artery reconstruction in diabetic patients with lower limb ischemia[J]. Chinese Journal of Surgery, 2010,48(4): 257-260.
[9] Pan ZJ, Zhang H, Li L, et al.Evaluation of early detection indicators of restenosis after femoral popliteal artery bypass grafting[J]. Chinese Journal of General Surgery, 2016,31(4): 305-307.
[10] Horie T, Kimura T, Ono K.Emerging novel biomarkers for arteriosclerosis obliterans[J]. J Atheroscler Thromb, 2016, 23(2): 171-172.
[11] Lu JY, Gu JP, Xu WJ, et al.Efficacy of drug-coated balloon and common balloon for treatment of superficial femoral artery and popliteal artery arteriosclerosis obliterans: prospective randomized controlled triac[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2017,37(3): 296-300.
[12] Lu WL, Wang B, Wu F, et al.Application of TurboHawk atherectomy device combined with drug-coated balloon in treatment of femoropopliteal occlusive diseases[J]. Chinese Journal of General Surgery, 2018,27(6): 692-698.
[13] Wu YB, Zhu YF, Ge HW, et al.Treatment of in-stent restenosis after endovascular treatment for lower extremity arteriosclerosis obliterans[J]. Chinese Journal of General Surgery, 2015,24(12): 1687-1690.
[14] Gerhard-Herman MD, Gornik HL, Barrett C, et al.2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Circulation[J]. Circulation, 2017,135(12): e686-e725.
[15] Matsushita K, Ballew SH, Sang Y, et al.Ankle-brachial index and physical function in older individuals: The Atherosclerosis Risk in Communities (ARIC) study[J]. Atherosclerosis, 2017,257: 208-215.
[16] Fowkes FG, Rudan D, Rudan I, et al.Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis[J]. Lancet, 2013,382(9901): 1329-1340.
[17] Hirsch AT, Duval S.The global pandemic of peripheral artery disease[J]. Lancet, 2013,382(9901): 1312-1314.
[18] Vogt MT, Cauley JA, Kuller LH, et al.Functional status and mobility among elderly women with lower extremity arterial disease: the study of osteoporotic fractures[J]. J Am Geriatr Soc, 1994,42(9): 923-929.
[19] Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) [J]. Eur J Vasc Endovasc Surg, 2007,33 Suppl 1: S1-S75.
[20] Writing Committee Members, Gerhard-Herman MD, Gornik HL, et al.2016 AHA/ACC Guideline on the Management of patients with lower extremity peripheral artery disease: executive summary[J]. Vasc Med, 2017,22(3): NP1-NP43.
[21] Shen H.Treatment of restenosis after stenting for lower extremity arteriosclerosis obliterans[J]. Journal of Shenyang Medical College, 2014,16(4): 193-198.
[22] Shen CY, Li WH.Interpretation and consideration of the Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities management of asymptomatic disease and claudication[J]. Zhonghua Wai Ke Za Zhi, 2016,54(2): 81-83.
[23] Jiao YH.Drug-coated balloon in treatment of lower limb atherosclerosis obliterans: current status[J]. Chinese Journal of General Surgery, 2018,27(6): 761-767.
[24] Zhao Y, Yuan Y, Liu H, et al.Evaluation of clinical efficacy and safety of endovascular angioplasty in the treatment of lower extremity arteriosclerosis obliterans in the elderly[J]. Journal of Beihua University: Natural Science Edition, 2018,19(1): 68-72.
[25] Yuan Y, Cheng WL, Lu HJ.Application of Single-bend catheter thrombolysis in endovascular treatment of simple short-segment popliteal artery occlusion[J]. Chinese Journal of General Surgery, 2018,27(6): 699-704.
[26] Sun LK, Wang B, Wu F, et al.Clinical study of drug-coated balloon in the treatment of femoral and popliteal arteriosclerosis obliterans[J]. Chinese Journal of General Surgery, 2017,26(6): 806-811.
[27] Ding N, Kwak L, Ballew SH, et al.Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study[J]. Atherosclerosis, 2018,274: 86-93.
[28] Matsushita K, Kwak L, Yang C, et al.High-sensitivity cardiac troponin and natriuretic peptide with risk of lower-extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) Study[J]. Eur Heart J, 2018,39(25): 2412-2419.
[29] Wendt K, Kristiansen R, Krohg-Sorensen K, et al.Norwegian trends in numbers of lower extremity revascularisations and amputations including regional trends in endovascular treatments for peripheral arterial disease: a retrospective cross-sectional registry study from 2001 to 2014[J]. BMJ Open, 2017,7(11): e016210.
[30] Niu XY, Wang B, Wu F, et al.Hybrid surgical treatment of complex femoral and popliteal arteriosclerosis obliterans[J]. Chinese Journal of General Surgery, 2017,26(6): 722-728.
[31] Xiong J.Hybrid surgery for complex peripheral artery diseases involving common femoral artery: techniques and results[J]. Chinese Journal of General Surgery, 2017,26(12): 1525-1528.